Determination of specificity of siRNA knockdown. (A) qRT-PCR analysis of target mRNAs. For each target mRNA measurement, the values were normalized to a control which was treated with transfection reagent only (DharmaFECT 1 [DF1]). For HDAC1 and Daxx siRNA treatments, the levels of HDAC1, HDAC2, HDAC3, HDAC4, and Daxx mRNAs were measured. For HDAC2, HDAC3, and HDAC4 siRNAs, only the cognate target mRNA levels were measured (*). (B) Assessment of knockdown by Western blotting. TI-C cells were treated with 100 nM of siRNAs indicated above the panel and cells were processed for Western blotting after 72 h. GAPDH antibody was used to monitor recovery. Mock siRNA treatments were performed in duplicate. (C) Transfection of a plasmid encoding an siRNA-resistant form of HDAC1 mRNA. Silent mutations that destroy the HDAC1 siRNA 01 annealing site were introduced into an HDAC1 expression plasmid, as described in Materials and Methods. Mutant plasmids prepared in duplicate (R1, R2) or a wt control plasmid was introduced into TI-C cells along with the HDAC1 siRNA 01. GFP expression was monitored by FACS. As shown, HDAC 01 siRNA was capable of stimulating GFP reactivation after transfection of the wt HDAC1 plasmid. In contrast, the siRNA-resistant plasmids were able to repress GFP expression in the presence of the siRNA. (D) Localization of Daxx at the GFP promoter. ChIP analysis was carried out as described in Materials and Methods. Two primer sets were used, targeting the silent viral GFP promoter region or the active cellular β-actin gene. Experiments shown are representative, and the Daxx results are averages of triplicate immunoprecipitations. IgG, immunoglobulin G.